E.g., 22/01/2021
E.g., 22/01/2021

bioMérieux receives CE Mark certification for IVD products maketed in the European Union

08 January, 2004

Marcy l'Etoile, France - January 8th, 2004. bioMérieux has received CE Mark certifications for all of its in vitro diagnostic (IVD) products currently marketed in the European Union (EU). In compliance with the requirements of the 98/79/EC directive for CE Marking, which became applicable on...

Cepheid and bioMérieux enter into strategic commercial program

06 January, 2004

Cepheid (NASDAQ: CPHD) today announced that it has entered into a strategic commercial relationship with bioMerieux for bioMerieux to develop DNA testing products embodying its proprietary NASBA (Nucleic Acid Sequence-Based Amplification) technology to be run on...